Frontiers in Immunology (Sep 2023)

Case Report: Characterization of known (c.607G>C) and novel (c.416C>G) ELANE mutations in two Mexican families with congenital neutropenia

  • María Enriqueta Núñez-Núñez,
  • Juan Carlos Lona-Reyes,
  • Juan Carlos Lona-Reyes,
  • Brenda López-Barragán,
  • Rosa Margarita Cruz-Osorio,
  • Rosa Margarita Cruz-Osorio,
  • Bricia Melissa Gutiérrez-Zepeda,
  • Bricia Melissa Gutiérrez-Zepeda,
  • Antonio Quintero-Ramos,
  • Antonio Quintero-Ramos,
  • Denisse Stephania Becerra-Loaiza,
  • Denisse Stephania Becerra-Loaiza

DOI
https://doi.org/10.3389/fimmu.2023.1194262
Journal volume & issue
Vol. 14

Abstract

Read online

The most common causes of congenital neutropenia are mutations in the ELANE (Elastase, Neutrophil Expressed) gene (19p13.3), mostly in exon 5 and the distal portion of exon 4, which result in different clinical phenotypes of neutropenia. Here, we report two pathogenic mutations in ELANE, namely, c.607G>C (p.Gly203Arg) and a novel variant c.416C>G (p.Pro139Arg), found in two Mexican families ascertained via patients with congenital neutropenia who responded positively to the granulocyte colony-stimulating factor (G-CSF) treatment. These findings highlight the usefulness of identifying variants in patients with inborn errors of immunity for early clinical management and the need to rule out mosaicism in noncarrier parents with more than one case in the family.

Keywords